Kawasaki-Like disease associated with COVID 19 in pediatrics: About a case

Authors

  • Javier Ignacio Servicio de Pediatría, Hospital II-2, Tarapoto, Perú
  • Telésforo Sánchez Servicio de Pediatría, Hospital II-2, Tarapoto, Perú
  • Estephanie Villasis Servicio de Pediatría, Hospital II-2, Tarapoto, Perú
  • Hypatia Requejo Servicio de Pediatría, Hospital II-2, Tarapoto, Perú
  • Heriberto Arévalo Laboratorio referencial Regional de Salud Pública, San Martín, Perú

DOI:

https://doi.org/10.61651/rped.2022v74n1p23-29

Keywords:

COVID 19, Mucocutaneous Lymph Node Syndrome, Child, SARS-CoV-2

Abstract

Since April 2020, data on Kawasaki syndrome and the hyper inflammatory response in children associated with COVID-19 have emerged rapidly. Much is still unknown about risk factors, pathogenesis, prognosis, and specific therapy for this emerging manifestation of COVID-19 known as Multisystemic Inflammatory Syndrome in Children (MIS-C). MIS-C is rare and early recognition is crucial, although standardized treatment guidelines have not been established. It is the first case of a patient admitted with a diagnosis of Kawasaki disease (EK) associated with COVID 19, in Tarapoto city, department of San Martin. She is a 6-year-old female patient, who is admitted to the hospital, presenting persistent fever of 5 days, urticariform rash, unilateral cervical lymphadenopathy, raspberry tongue, red and cracked lips, erythema of pulp of fingers and toes, with molecular test SARS-CoV-2 POSITIVE (Ct: 32.5),start treatment with Immunoglobulin 2gr / kg / d, with favorable evolution.

Downloads

Download data is not yet available.

Downloads

Published

2022-12-31

How to Cite

1.
Ignacio J, Sánchez T, Villasis E, Requejo H, Arévalo H. Kawasaki-Like disease associated with COVID 19 in pediatrics: About a case. Rev Peru Pediatr [Internet]. 2022 Dec. 31 [cited 2024 Sep. 16];74(1):23-9. Available from: https://pediatria.pe/index.php/pedperu/article/view/340

Issue

Vol. 74 Num. 1 (2022)

Section

CLINICAL CASE

Categories

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors will retain the copyright and grant the right to publish their work in the journal while allowing third parties to share it under the Creative Commons Attribution license.

Articles are published under a Creative Commons license that allows sharing and adaptation with appropriate credit. CC BY 4.0 license. Available in English at https://creativecommons.org/licenses/by/4.0/

Authors may use other information disclosure formats as long as the initial publication in the journal is cited. The dissemination of the work through the Internet is recommended to increase citations and promote academic exchanges.

The published content does not necessarily reflect the specific point of view of the journal, and the authors assume full responsibility for the content of their article.